9/22/2021  5:35:28 PM Chg. -1.80 Volume Bid5:35:28 PM Ask9/22/2021 Market Capitalization Dividend Y. P/E Ratio
135.40EUR -1.31% 4,821
Turnover: 653,491.20
-Bid Size: - -Ask Size: - 1.63 bill.EUR 0.66% 64.78

Business description

STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers integrated laboratory software and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain - from development to design and production through to quality assurance. The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies. Shares in the company are traded in the Prime Standard segment of the Frankfurt Stock Exchange.

Management board & Supervisory board

Marcus Wolfinger
Management board
Dr. Claus Vielsack, Dr. Robert Siegle
Supervisory board
Prof. Dr. Stefanie Remmele, Dr. Frank Hiller, Dr. Rolf Vornhagen

Company data

Address: Gewerbestraße 37,D-75217 Birkenfeld
Phone: +49-7082-7916-0
Fax: +49-7082-7916-9190
E-mail: info@stratec.com
Internet: www.stratec.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 58.88%
IPO date: 8/25/1998

Investor relations

Name: Jan Keppeler
IR phone: +49-7082-7916-991
IR Fax: -
IR e-mail: ir@stratec.com

Company calendar

CW 46 | 11/11/2021 Interim Report 3rd Quarter/9 Months

Main Shareholders

Herrmann Leistner und Familie
eigene Aktien